An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Moderate and Severe COVID-19
- SARS CoV-2 Infection
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04575064
- Collaborators
- Dept. of Statistics and Medical Biometry, University of Bremen
- INSERM (Institut national de la santé et de la recherche médicale), Paris, France
- World Health Organization (WHO), R&D Blueprint, Geneva, Switzerland
- Investigators
- Principal Investigator: Tobias Welte, MD, Prof. Hannover Medical School
Get Well Soon